Skip to main content
Skip to main content
MenuSearch & Directory

Professor Ana Santos Rutschman Joins Biden Advisory Committee

Media Inquiries

Jessica L. Ciccone
Director of Communications, Saint Louis University School of Law
jessica.ciccone@slu.edu
(314) 977-7248

Reserved for members of the media.

Professor Ana Santos Rutschman has been named to former vice president Joe Biden’s COVID-19 Innovation Committee. An expert in vaccine law and policy, Rutschman is assigned to the COVID-19 Response Subcommittee.

The committee has been investigating vaccines, treatments, and other medical technologies related to COVID-19. Additionally, they are analyzing the work of Operation Warp Speed and making recommendations on the relationship between the United States and the World Health Organization. Stef Feldman, the policy director for the Biden campaign, oversees the policy efforts for all committees.

Professor Ana Santos Rutschman
 Professor Ana Santos Rutschman teaching FDA Law and Policy

Rutschman’s work with the committee has been primarily focused on vaccines and intellectual property issues.

“It’s been really instructive for me,” says Rutschman. “Although I have done consulting work on vaccines and intellectual property before, my notions of what domestic policy looked like in these areas were mostly informed by watching West Wing. This opportunity has shown me how policy from scratch really works.”

Rutschman joined the SLU LAW faculty in 2018 and is a member of the Center for Health Law Studies and the Center for International and Comparative Law. She previously taught at DePaul University College of Law as the inaugural Jaharis Fellow in Health Law and Intellectual Property (2016-2018). Rutschman was a consultant to the World Health Organization in 2015-2016, as well as a visiting guest lecturer in intellectual property at Uppsala Law School (Sweden) in Fall 2015. She holds a S.J.D. and LL.M. from Duke University and a law degree from Catholic University in Portugal.

Learn more about the Health Law response to COVID-19
Learn more about the Center for Health Law Studies
Learn more about the Center for International and Comparative Law